WO2006113925A3 - Composition et utilisation de phyto-percolate pour le traitement d'une maladie - Google Patents
Composition et utilisation de phyto-percolate pour le traitement d'une maladie Download PDFInfo
- Publication number
- WO2006113925A3 WO2006113925A3 PCT/US2006/015302 US2006015302W WO2006113925A3 WO 2006113925 A3 WO2006113925 A3 WO 2006113925A3 US 2006015302 W US2006015302 W US 2006015302W WO 2006113925 A3 WO2006113925 A3 WO 2006113925A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- phyto
- percolate
- disease
- treatment
- composition
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 241000195493 Cryptophyta Species 0.000 abstract 1
- 102000009123 Fibrin Human genes 0.000 abstract 1
- 108010073385 Fibrin Proteins 0.000 abstract 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229950003499 fibrin Drugs 0.000 abstract 1
- 239000013505 freshwater Substances 0.000 abstract 1
- 230000036542 oxidative stress Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002625818A CA2625818A1 (fr) | 2005-04-20 | 2006-04-20 | Composition et utilisation de phyto-percolate pour le traitement d'une maladie |
EP06758513A EP1928247A4 (fr) | 2005-04-20 | 2006-04-20 | Composition et utilisation de phyto-percolate pour le traitement d'une maladie |
US12/067,735 US8586053B2 (en) | 2005-09-21 | 2006-04-20 | Composition and use of phyto-percolate for treatment of disease |
US11/606,676 US7807622B2 (en) | 2004-04-23 | 2006-11-30 | Composition and use of phyto-percolate for treatment of disease |
US12/897,574 US8791060B2 (en) | 2004-04-23 | 2010-10-04 | Composition and use of phyto-percolate for treatment of disease |
US14/558,516 US10166270B2 (en) | 2004-04-23 | 2014-12-02 | Composition and method for affecting cytokines and NF-κB |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
USPCT/US2005/13375 | 2005-04-20 | ||
PCT/US2005/013375 WO2005112987A2 (fr) | 2004-04-23 | 2005-04-20 | Procede de preparation et d'utilisation d'enzymes fibrinolytiques pour le traitement d'une maladie |
US71902505P | 2005-09-21 | 2005-09-21 | |
US60/719,025 | 2005-09-21 | ||
US74177405P | 2005-12-02 | 2005-12-02 | |
US60/741,774 | 2005-12-02 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/013375 Continuation-In-Part WO2005112987A2 (fr) | 2004-04-23 | 2005-04-20 | Procede de preparation et d'utilisation d'enzymes fibrinolytiques pour le traitement d'une maladie |
Related Child Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/013375 Continuation-In-Part WO2005112987A2 (fr) | 2004-04-23 | 2005-04-20 | Procede de preparation et d'utilisation d'enzymes fibrinolytiques pour le traitement d'une maladie |
US11/606,676 Continuation-In-Part US7807622B2 (en) | 2004-04-23 | 2006-11-30 | Composition and use of phyto-percolate for treatment of disease |
AU2006320264A Division AU2006320264A1 (en) | 2005-04-20 | 2006-12-04 | Composition and use of phyto-percolate for treatment of disease |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006113925A2 WO2006113925A2 (fr) | 2006-10-26 |
WO2006113925A3 true WO2006113925A3 (fr) | 2007-06-14 |
Family
ID=37115978
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/015302 WO2006113925A2 (fr) | 2004-04-23 | 2006-04-20 | Composition et utilisation de phyto-percolate pour le traitement d'une maladie |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP1928247A4 (fr) |
WO (1) | WO2006113925A2 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10166270B2 (en) | 2004-04-23 | 2019-01-01 | Zivo Bioscience, Inc. | Composition and method for affecting cytokines and NF-κB |
US7807622B2 (en) | 2004-04-23 | 2010-10-05 | Health Enhancement Products, Inc. | Composition and use of phyto-percolate for treatment of disease |
US8586053B2 (en) | 2005-09-21 | 2013-11-19 | Health Enhancement Products, Inc. | Composition and use of phyto-percolate for treatment of disease |
WO2008040516A2 (fr) * | 2006-10-02 | 2008-04-10 | Georg Fritzmeier Gmbh & Co. Kg | Composition microbiologique et son utilisation |
WO2011103569A1 (fr) | 2010-02-22 | 2011-08-25 | Health Enhancement Products, Inc. | Agents et mécanismes de traitement de l'hypercholestérolémie |
US10232028B2 (en) | 2013-06-13 | 2019-03-19 | Zivo Bioscience, Inc. | Compounds and methods for affecting cytokines |
ES2972377T3 (es) | 2015-02-16 | 2024-06-12 | Zivo Bioscience Inc | Composiciones antinflamatorias e inmunomoduladoras que comprenden Klebsormidium y usos de las mismas |
MX2018009819A (es) | 2016-02-16 | 2019-02-20 | Zivo Bioscience Inc | Soporte nutricional para animales mediante la administracion de un suplemento derivado de algas. |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6461607B1 (en) * | 1998-08-24 | 2002-10-08 | Ganeden Biotech, Inc. | Probiotic, lactic acid-producing bacteria and uses thereof |
US6723326B1 (en) * | 1997-04-18 | 2004-04-20 | Ganeden Biotech, Inc. | Topical compositions containing probiotic Bacillus bacteria, spores, and extracellular products and uses thereof |
US6733751B2 (en) * | 1999-08-26 | 2004-05-11 | Ganeden Biotech, Inc. | Use of Emu Oil and its various fractions as a carrier for antifungal, antibacterial, and antiviral medications & preparations |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2564466A1 (fr) * | 2004-04-23 | 2005-12-01 | Health Enhancement Products, Inc. | Procede de preparation et d'utilisation d'enzymes fibrinolytiques pour le traitement d'une maladie |
-
2006
- 2006-04-20 WO PCT/US2006/015302 patent/WO2006113925A2/fr active Application Filing
- 2006-04-20 EP EP06758513A patent/EP1928247A4/fr not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6723326B1 (en) * | 1997-04-18 | 2004-04-20 | Ganeden Biotech, Inc. | Topical compositions containing probiotic Bacillus bacteria, spores, and extracellular products and uses thereof |
US6461607B1 (en) * | 1998-08-24 | 2002-10-08 | Ganeden Biotech, Inc. | Probiotic, lactic acid-producing bacteria and uses thereof |
US6733751B2 (en) * | 1999-08-26 | 2004-05-11 | Ganeden Biotech, Inc. | Use of Emu Oil and its various fractions as a carrier for antifungal, antibacterial, and antiviral medications & preparations |
Non-Patent Citations (1)
Title |
---|
See also references of EP1928247A4 * |
Also Published As
Publication number | Publication date |
---|---|
EP1928247A4 (fr) | 2009-10-28 |
EP1928247A2 (fr) | 2008-06-11 |
WO2006113925A2 (fr) | 2006-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006113925A3 (fr) | Composition et utilisation de phyto-percolate pour le traitement d'une maladie | |
WO2005067546A3 (fr) | Derives et analogues de pyrrolopyrimidine et utilisation de ceux-ci dans le traitement a la prevention de maladies | |
WO2007065024A3 (fr) | Composition et utilisation d'un phyto-percolate pour le traitement d'une maladie | |
WO2006097793A3 (fr) | Compositions capables de faciliter la penetration a travers une barriere biologique | |
WO2006034373A8 (fr) | Variants et variants chimiquement modifies de phenylalanine ammonia-lyase | |
WO2007112052A3 (fr) | Formulations et méthodes destinées aux maladies ou aux pathologies liées à la perméabilité vasculaire | |
WO2007089584A3 (fr) | Compositions et leurs utilisations visant la huntingtine | |
EP2275543A3 (fr) | Compositions et leurs utilisations dirigées vers l'hepcidine | |
WO2008057459A3 (fr) | Antagonistes de pcsk9 | |
WO2008057457A3 (fr) | Antagonistes de pcsk9 | |
WO2008057458A3 (fr) | Antagonistes de pcsk9 | |
WO2008133647A3 (fr) | Antagonistes de pcsk9 | |
WO2006068729A3 (fr) | Procedes et compositions pour ameliorer l'absorption de fer | |
WO2007002836A3 (fr) | Procedes et compositions pour la prevention et le traitement de maladie renale | |
MY143795A (en) | Tetrahydropyridoindole derivatives | |
WO2006128125A3 (fr) | Methodes et compositions pour stimuler le captage du glucose dans des cellules musculaires et pour traiter des maladies | |
ZA200610353B (en) | Treatment or prevention of skin conditions or tissue conditions in animals using boryloxypyridylmenthanones | |
WO2005076979A3 (fr) | Diagnostics et therapeutiques du cancer | |
WO2005113752A3 (fr) | Procedes et compositions de production de cellules souches a partir de cellules souches de lignee germinale derivees de sang peripherique | |
WO2008039941A3 (fr) | Protéine scgb3a2 utilisée en tant que facteur de croissance et qu'agent anti-apoptotique | |
WO2002067971A3 (fr) | Traitement de la neovasculatisation oculaire | |
WO2008066775A3 (fr) | Compositions et procédés visant à réduire la graisse et à rétracter la peau | |
WO2007025229A3 (fr) | Compositions et utilisations contre hsp27 | |
CA2522824A1 (fr) | Composition proteique musculaire animale fonctionnelle a faible taux de cholesterol et procede associe | |
WO2005112987A3 (fr) | Procede de preparation et d'utilisation d'enzymes fibrinolytiques pour le traitement d'une maladie |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 11606676 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006758513 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2008532207 Country of ref document: JP Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2625818 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12067735 Country of ref document: US |